Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 09 April 2026
      Europe’s Choice: Investing in sustainable health systems | 21 April

European health and social care systems are under intense pressure.

With strained budgets, growing pressure on public finances, a deepening workforce crisis, and an uncertain geopolitical landscape, the need to rethink healthcare in Europe has never been more urgent.

Join us on 21 April to explore the challenges and opportunities in implementing effective screening programmes and diagnostics in oncology, and the meaningful impact these can have for patients and society as a whole.

Discover the programme and register here.

 
      Discover EFPIA's latest publication

What could the next decade look like for Europe by closing the competitiveness gap with other regions?

Read our report to see where Europe performs well and where it needs to catch up. 

 
 
      Events
 
 
19 MAY 2026
  European Pharmaceutical Law Forum Brussels, Belgium

The European pharmaceutical market is facing a moment of profound change. With sweeping updates to the EU pharmaceutical...

Learn more →
 
 
 
 
17 JUN 2026
  Inaugural Forum on Life Sciences Product Liability, Policy & Dispute Resolution Europe... Brussels, Belgium

The must-attend European defense strategy forum for the life sciences litigation community. Europe’s Premier Forum for...

Learn more →
 
 
 
 
      What we are reading
Together for health, stand with science 07 April 2026  (IHI)

The theme for this year’s World Health Day is Together for Health, Stand with Science, highlighting how scientific...

Read more →
Biotech Act must deliver, not become a ‘paper monster’, says Belgian MEP Beke 03 April 2026  (Euractiv)

Speeding up clinical trials must be a central test of the EU’s proposed Biotech Act, as Europe risks forfeiting the...

Read more →
Swedish study: HPV vaccines protect against cervical cancer after 18 years 25 March 2026  (Vaccines Today)

Most cases of cervical cancer are caused by human papillomaviruses (HPV). When HPV vaccines were introduced twenty...

Read more →
 
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
X in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe